---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005002"
form_type: "8-K"
ticker: "BCAX"
cik: "0002023658"
company_name: "Bicara Therapeutics Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T04:04:30.933627+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Bicara Therapeutics furnishes corporate presentation, no new material disclosures

## Summary
- Presentation is a general corporate overview; no financial results or guidance provided.
- Presentation to be used in investor meetings starting January 13, 2025.
- Presentation available on company's IR website at ir.bicara.com.

## SEC filing metadata
- accession: 0001193125-25-005002
- form_type: 8-K
- ticker: BCAX
- cik: 0002023658
- company_name: Bicara Therapeutics Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023658/000119312525005002/0001193125-25-005002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023658/000119312525005002/d904889d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005002
- JSON: https://secwatch.observer/filing/0001193125-25-005002.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.